CVI Holdings’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,000	Closed	-$3.53M	–	976
2021 Q3	$3.53M	Hold	35,000	–	–	0.22%	155
2021 Q2	$3.49M	Buy	+35,000	New	+$3.49M	0.24%	140